pin-white

Date

May 20-24

Location

Montréal, Canada

Meet us at CYTO 2023

CYTO 2023, the Congress for the International Society for the Advancement of Cytometry will be a premier, inclusive, and international conference on the many facets of cytometry science and engineering.

Meet the Cerba Research flow cytometry team and discover how Cerba Research is committed to validating your assay with standardized instruments across labs, by applying independent quality control steps to monitor instrument performance.

Complex flow cytometry is critical for today’s personalized medicine. With 25 years of extensive expertise in providing flow cytometry testing for clinical trials ranging from phase I to phase III, Cerba Research has a strong track record of developing and validating custom-made flow cytometry panels. Monitor immunophenotyping, immune cell activation, receptor occupancy of the drug, and the workings of CAR-T cells through flow cytometry on blood samples and bone marrow aspirate.

Ans De Beuckelaer

Regional Head Flow Cytometry EU

With the breakthrough of cellular immune therapies, such as CAR+ T, flow cytometry became a critical platform, not only for the clinical laboratories, but also for drug developers and manufacturers. Indeed, flow cytometry plays a crucial role in the production process of CAR+ T cells where it is used for assessing transduction efficiency, purity and characterization of the CAR+ T product before infusion. But also after manufacturing, when CAR+ T cells are infused into the patients, flow cytometry is used in clinical laboratories to assess CAR+ T expansion, efficiency and persistency and to monitor minimal residual disease (MRD).

Our Flow Cytometry Services

Flow Cytometry Biomarkers and Panels

We develop and validate assays as well as creating drug-specific flow cytometry panels tailored specifically to your study. Find out how we can support your research.

Discover more
DSC00192-2048x1365

Flow cytometry assay development

From cellular subtype identification to immunophenotyping to measure drug occupancy of cellular target markers, Cerba Research offers  tailor-made assay development dedicated to the objectives of your clinical trial.

Discover more

Reporting

With our extended expertise in panel design, assays development/validation and data analysis, Cerba Research provides you a regular and accurate reporting.

Discover more

Reach out to our experts and discover how we can help you transform your research and advance health with flow cytometry.